The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NCI 10479: A phase I dose escalation-expansion trial of sunitinib malate plus lutetium (Lu-177) dotatate in somatostatin receptor positive pancreatic neuroendocrine tumors.
 
Nikolaos Trikalinos
Research Funding - Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Exelixis (Inst); Merck (Inst); Novartis (Inst); Nykode Therapeutics (Inst)
 
Haeseong Park
Consulting or Advisory Role - Merck
Research Funding - Amgen (Inst); Bolt Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); D3Bio (Inst); Exelixis (Inst); Huoata Bio (Inst); Idience (Inst); Incyte (Inst); Mersana (Inst); Mirati Therapeutics (Inst); Strata Oncology (Inst); Tizona Therapeutics, Inc. (Inst)
Travel, Accommodations, Expenses - Amgen
 
Hyun Kim
Honoraria - Varian Medical Systems; ViewRay
Consulting or Advisory Role - Novartis; Varian Medical Systems
Research Funding - Varian Medical Systems; ViewRay
Travel, Accommodations, Expenses - Elekta; Varian Medical Systems; ViewRay
 
Vikas Prasad
Consulting or Advisory Role - Bayer HealthCare Pharmacuticals; Cellectar; Curium Pharma; Lantheus Medical Imaging; Lilly; Telix Pharmaceuticals
Speakers' Bureau - Curium Pharma
Travel, Accommodations, Expenses - RayzeBio; Telix Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - ECOG-ACRIN; ENETS; ESMO; ICPO Foundation; SNMMI
 
Feng Gao
No Relationships to Disclose
 
Lorraine Pelosof
No Relationships to Disclose
 
Amir Iravani
Consulting or Advisory Role - Lantheus Medical Imaging; Novartis
 
Manik Amin
No Relationships to Disclose
 
Kian-Huat Lim
Honoraria - CURIS
Patents, Royalties, Other Intellectual Property - Hold patent for targeting MK2 as a therapeutic strategy in pancreatic cancer.